| Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. | Lancet Oncology, The | 2022 | 58 |
| Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA. | Journal of Clinical Oncology | 2022 | 36 |
| Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. | Lancet, The | 2022 | 35 |
| Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. | New England Journal of Medicine | 2022 | 30 |
| Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study. | Hepatology | 2022 | 6 |
| Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography: update 2022. | Cardiovascular Intervention and Therapeutics | 2022 | 5 |
| Two-year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemia. | Cancer Science | 2022 | 4 |
| JCS 2018 Guideline on Revascularization of Stable Coronary Artery Disease. | Circulation Journal | 2022 | 3 |
| Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma. | Journal of Allergy and Clinical Immunology: in Practice | 2022 | 3 |
| Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020. | Journal of Gastroenterology | 2022 | 3 |
| HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway. | Journal of Experimental and Clinical Cancer Research | 2022 | 3 |
| Case Report: New-Onset Rheumatoid Arthritis Following COVID-19 Vaccination | Frontiers in Immunology | 2022 | 3 |
| Estimating radiation exposure of the brain of a physician with a protective flap in interventional radiology: A phantom study. | Journal of Applied Clinical Medical Physics | 2022 | 2 |
| Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report. | BMC Medical Genomics | 2022 | 2 |
| Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease. | Scientific Reports | 2022 | 2 |
| Clinical practice guidelines for pseudoxanthoma elasticum (2017): Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee: Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee. | Journal of Dermatology | 2022 | 2 |
| TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization combined with atezolizumab + bevacizumab or on-demand transarterial chemoembolization alone in patients with untreated hepatocellular carcinoma. | Journal of Clinical Oncology | 2022 | 2 |
| Consensus for HER2 alterations testing in non-small-cell lung cancer. | ESMO Open | 2022 | 2 |
| Initial evaluation of a new maximum-likelihood attenuation correction factor-based attenuation correction for time-of-flight brain PET. | Annals of Nuclear Medicine | 2022 | 2 |
| A Deep Learning System to Diagnose COVID-19 Pneumonia Using Masked Lung CT Images to Avoid AI-generated COVID-19 Diagnoses that Include Data outside the Lungs | Advanced Biomedical Engineering | 2022 | 2 |
| Impact of modifiable healthy lifestyle adoption on lifetime gain from middle to older age. | Age and Ageing | 2022 | 2 |
| ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer. | Annals of Oncology | 2022 | 2 |
| What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. | European Urology | 2022 | 2 |
| Connecting the Dots Between the Gut-IGF-1-Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis. | Frontiers in Endocrinology | 2022 | 2 |
| Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101. | ESMO Open | 2022 | 2 |
